These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24490472)

  • 21. Excipient-drug interactions in parenteral formulations.
    Akers MJ
    J Pharm Sci; 2002 Nov; 91(11):2283-300. PubMed ID: 12379914
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Breakout session summary from AAPS/CRS joint workshop on critical variables in the in vitro and in vivo performance of parenteral sustained release products.
    Martinez MN; Rathbone MJ; Burgess D; Huynh M
    J Control Release; 2010 Feb; 142(1):2-7. PubMed ID: 19808069
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Conventional versus novel conditions for the in vitro dissolution testing of parenteral slow release formulations: application to doxepin parenteral dosage forms.
    Gido C; Langguth P; Kreuter J; Winter G; Woog H; Mutschler E
    Pharmazie; 1993 Oct; 48(10):764-9. PubMed ID: 8265710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Manufacture and in vitro characterization of a new fluid theophylline sustained-release form. Sachets with microcapsules for administration in a drinkable sustained-release suspension].
    Weiss G; Klemm FH; Fuchs WS; Stanislaus F; Zema M; Calanchi M
    Arzneimittelforschung; 1998 May; 48(5A):604-12. PubMed ID: 9676353
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality concept of parenterals in Europe.
    Möller H
    PDA J Pharm Sci Technol; 1995; 49(4):196-201. PubMed ID: 7552241
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Natural polymers, gums and mucilages as excipients in drug delivery.
    Kumar S; Gupta SK
    Polim Med; 2012; 42(3-4):191-7. PubMed ID: 23457960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Advances in psychotropic formulations.
    Keith S
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):996-1008. PubMed ID: 16678954
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Parenteral drug delivery: a review.
    Gulati N; Gupta H
    Recent Pat Drug Deliv Formul; 2011 May; 5(2):133-45. PubMed ID: 21453250
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evaluation of pain and irritation following local administration of parenteral formulations using the rat paw lick model.
    Gupta PK; Patel JP; Hahn KR
    J Pharm Sci Technol; 1994; 48(3):159-66. PubMed ID: 8069518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The use of oil-in-water emulsions as a vehicle for parenteral drug administration.
    Prankerd RJ; Stella VJ
    J Parenter Sci Technol; 1990; 44(3):139-49. PubMed ID: 2196363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Terminology challenges: defining modified release dosage forms in veterinary medicine.
    Martinez MN; Lindquist D; Modric S
    J Pharm Sci; 2010 Aug; 99(8):3281-90. PubMed ID: 20213837
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release.
    Kim JK; Park JS; Kim CK
    Int J Pharm; 2010 Jan; 383(1-2):209-15. PubMed ID: 19747966
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Application of organogels as oral controlled release formulations of hydrophilic drugs.
    Iwanaga K; Kawai M; Miyazaki M; Kakemi M
    Int J Pharm; 2012 Oct; 436(1-2):869-72. PubMed ID: 22766444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Injection Molding and its application to drug delivery.
    Zema L; Loreti G; Melocchi A; Maroni A; Gazzaniga A
    J Control Release; 2012 May; 159(3):324-31. PubMed ID: 22245483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Solutions as solutions--synthesis and use of a liquid polyester excipient to dissolve lipophilic drugs and formulate sustained-release parenterals.
    Asmus LR; Gurny R; Möller M
    Eur J Pharm Biopharm; 2011 Nov; 79(3):584-91. PubMed ID: 21820511
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of formulation of intramuscular injections of phenothiazines on duration of activity.
    Florence AT; Jenkins AW; Loveless AH
    J Pharm Sci; 1976 Nov; 65(11):1665-8. PubMed ID: 11335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Difficulties encountered during formulation of a parenteral dosage form containing a poorly soluble drug].
    Kovács K; Orosz T; Stampf G; Antal I; Klebovich I; Ludányi K
    Acta Pharm Hung; 2009; 79(1):35-44. PubMed ID: 19526681
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Filler-controlled release from suspension matrices (laminates)].
    Lippold BC; Kurka P
    Pharmazie; 1987 Nov; 42(11):729-31. PubMed ID: 3438337
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study of the preparation of sustained-release microspheres containing zedoary turmeric oil by the emulsion-solvent-diffusion method and evaluation of the self-emulsification and bioavailability of the oil.
    You J; Cui FD; Han X; Wang YS; Yang L; Yu YW; Li QP
    Colloids Surf B Biointerfaces; 2006 Mar; 48(1):35-41. PubMed ID: 16480856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.